neutral rating,0.378657
Point Partners LLC,0.517267
drug-resistant infectious diseases,-0.605889
clinical-stage biopharmaceutical company,0.298413
52-week low,-0.718613
price objective,0.378657
strong-buy rating,0.347383
life-threatening multidrug-resistant infections,-0.766748
consensus price target,0.713383
stock,0.366466
InvestorPlace Broker Center,0.555736
oral antibiotic,-0.475525
biopharmaceutical company,0.395198
sell rating,0.320798
personal trading style,0.598412
Millennium Management LLC,0.218959
life science company,-0.605889
target price,0.347383
Pharmaceuticals Inc Daily,0.397938
buy rating,0.36302
tetracycline based drugs,-0.605889
shares,0.428135
concise daily summary,0.505807
Tetraphase Pharmaceuticals,-0.0567206
Gram-negative infections,-0.475525
Great Point Partners,0.517267
stock broker,0.245696
mid-day trading,-0.321438
consensus rating,0.713383
equities research analyst,0.320798
quarter,-0.154987
